Cargando…
mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292566/ http://dx.doi.org/10.1186/2051-1426-2-S3-P262 |
| _version_ | 1782352502016966656 |
|---|---|
| author | Rubin-Bejerano, Ifat Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua |
| author_facet | Rubin-Bejerano, Ifat Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua |
| author_sort | Rubin-Bejerano, Ifat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292566 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42925662015-01-15 mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils Rubin-Bejerano, Ifat Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292566/ http://dx.doi.org/10.1186/2051-1426-2-S3-P262 Text en Copyright © 2014 Rubin-Bejerano et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Rubin-Bejerano, Ifat Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title | mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title_full | mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title_fullStr | mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title_full_unstemmed | mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title_short | mAbXcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| title_sort | mabxcite: a novel immunotherapy platform that initiates a robust anti-cancer immune response by recruiting and activating neutrophils |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292566/ http://dx.doi.org/10.1186/2051-1426-2-S3-P262 |
| work_keys_str_mv | AT rubinbejeranoifat mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT sansalcastellanoisabelle mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT carlsonmark mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT reznikgabriel mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT siedleckijames mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT kanejohn mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT dostalovazuzana mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils AT miaohua mabxciteanovelimmunotherapyplatformthatinitiatesarobustanticancerimmuneresponsebyrecruitingandactivatingneutrophils |